1. Home
  2. ELUT vs LEVI Comparison

ELUT vs LEVI Comparison

Compare ELUT & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • LEVI
  • Stock Information
  • Founded
  • ELUT 2015
  • LEVI 1853
  • Country
  • ELUT United States
  • LEVI United States
  • Employees
  • ELUT N/A
  • LEVI N/A
  • Industry
  • ELUT Medical Specialities
  • LEVI Apparel
  • Sector
  • ELUT Health Care
  • LEVI Consumer Discretionary
  • Exchange
  • ELUT Nasdaq
  • LEVI Nasdaq
  • Market Cap
  • ELUT 94.0M
  • LEVI 6.2B
  • IPO Year
  • ELUT 2020
  • LEVI 2019
  • Fundamental
  • Price
  • ELUT $1.99
  • LEVI $17.19
  • Analyst Decision
  • ELUT Strong Buy
  • LEVI Strong Buy
  • Analyst Count
  • ELUT 2
  • LEVI 11
  • Target Price
  • ELUT $9.00
  • LEVI $19.45
  • AVG Volume (30 Days)
  • ELUT 40.2K
  • LEVI 2.4M
  • Earning Date
  • ELUT 05-08-2025
  • LEVI 06-25-2025
  • Dividend Yield
  • ELUT N/A
  • LEVI 3.05%
  • EPS Growth
  • ELUT N/A
  • LEVI 195.92
  • EPS
  • ELUT N/A
  • LEVI 0.89
  • Revenue
  • ELUT $24,375,000.00
  • LEVI $6,401,900,000.00
  • Revenue This Year
  • ELUT $39.35
  • LEVI N/A
  • Revenue Next Year
  • ELUT $61.26
  • LEVI $5.02
  • P/E Ratio
  • ELUT N/A
  • LEVI $19.26
  • Revenue Growth
  • ELUT N/A
  • LEVI 7.23
  • 52 Week Low
  • ELUT $1.79
  • LEVI $12.17
  • 52 Week High
  • ELUT $5.24
  • LEVI $24.34
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 39.97
  • LEVI 62.77
  • Support Level
  • ELUT $1.79
  • LEVI $15.97
  • Resistance Level
  • ELUT $2.07
  • LEVI $17.27
  • Average True Range (ATR)
  • ELUT 0.20
  • LEVI 0.46
  • MACD
  • ELUT -0.00
  • LEVI 0.20
  • Stochastic Oscillator
  • ELUT 33.08
  • LEVI 90.18

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Share on Social Networks: